Category - Pharma Industry News
Tecentriq, Kesimpta lead latest SMC decisions
Novo Nordisk signs deal for Prothena’s heart drug worth up to $1.2bn
Philip Morris International to acquire inhaled drug company Vectura for $1.2bn
The time for quality content standards is now
FDA acting commissioner Janet Woodcock requests independent review of Aduhelm approval
bluebird bio to restart marketing of Zynteglo in EU after previous suspension
Supply chain security stays top of mind in generics
Galapagos’ filgotinib leads to rapid symptom improvement for ulcerative colitis patients